| SUBJECT |
|
Paper # |
Year published |
| ACEPROMAZINE |
|
|
|
|
Atypical conditions/ quantitative
recovery |
61 |
1981 |
|
Blockage of fentanyl locomotor response |
73 |
1982 |
|
Pharmacology & behavior (variable
interval) |
74 |
1981 |
|
Pharmacokinetics & pharmacology |
78 |
1982 |
|
ELISA & PCFIA detection |
144 |
1988 |
|
ELISA detection |
150 |
1988 |
|
Non-isotopic immunoassays (review) |
156 |
1989 |
|
Hematocrit values as threshold
indicator |
172 |
1992 |
|
Effects on spontaneous locomotor
activity |
250 |
1997 |
| ACIDIFICATION
OF URINE |
|
|
|
|
Population distribution & methods |
139 |
1990 |
|
Population parameters & methods |
151 |
1988 |
| ACUPUNCTURE |
|
|
|
|
Influence on pain threshold |
273 |
1999 |
| AGONISTS,
a2- |
|
|
|
|
Detection of detomidine by RIA |
153 |
1989 |
|
Detomidine clearance by ELISA |
180 |
1992 |
|
Immobilization of goats using
detomidine |
210 |
1997 |
|
Amitraz, detomidine and locomotor
activity |
224 |
1997 |
|
Antinociception & sedative effect
of amitraz |
231 |
1998 |
|
Amitraz, detomidine, acepromazine and
activity |
250 |
1997 |
|
Serum concentrations, effects of oral
detomidine |
271 |
2002 |
|
Biotransformation, pharmacokinetics of
guanabenz |
289 |
2003 |
|
Comparative clinical effects,
pharmacodynamics |
290 |
|
|
Pharmacodynamics of guanabenz and
related ... |
299 |
|
|
ELISA assay for guanabenz |
314 |
|
|
Detection and confirmation method for
amitraz |
322 |
|
|
ELISA assay for guanabenz |
333 |
|
| ALBUTEROL
(TORPEX®) |
|
|
|
|
ELISA detection times |
295 |
2002 |
|
ELISA detection times, preliminary
report |
297 |
|
| ALFENTANIL
(ALFENTA®) |
|
|
|
|
RIA & ELISA detection |
148 |
1988 |
|
ELISA & RIA detection |
155 |
1989 |
| AMANTADINE |
|
|
|
|
Pharmacology
and pharmacokinetics |
209 |
1996 |
|
Overview of pharmacology, side effects |
227 |
1996 |
|
Preliminary report: pharmacokinetics |
246 |
1995 |
| AMITRAZ |
|
|
|
|
Effect on spontaneous locomotor
activity |
224 |
1997 |
|
Antinociception & sedative effect |
231 |
1998 |
|
Locomotor
activity |
250 |
1997 |
|
Detection and confirmation method |
322 |
|
| ANABOLIC
STEROIDS |
|
|
|
|
Androgen group of drugs |
26 |
1978 |
|
Use & excretion data |
169 |
1989 |
| ANALGESICS |
|
|
|
|
Furosemide & pentazocine urinary
concentration |
18 |
1977 |
|
Furosemide & pentazocine
disposition |
22 |
1978 |
|
Detection & pharmacokinetics of
pentazocine |
27 |
1979 |
|
Detection of pentazocine & fentanyl |
31 |
1979 |
|
Opiate receptor |
32 |
1978 |
|
Locomotor effects/ fentanyl &
apomorphine |
38 |
1979 |
|
Six drugs: morphine, meperidine,
pentazocine, etc |
39 |
1979 |
|
Quantitation & blockage/ locomotor
response |
40 |
1978 |
|
Selective blockage/ locomotor response |
46 |
1981 |
|
Review: non-steroidal anti-inflammatory
drugs |
55 |
1979 |
|
Pharmacokinetics & locomotor
response of fentanyl |
59 |
1979 |
|
Detection of morphine (GC) |
65 |
1981 |
|
Method for pain perception |
104 |
1985 |
|
Autonomic & behavioral response of
fentanyl |
106 |
1985 |
|
-Opioid
receptor narcotics |
110 |
1985 |
|
RIA screening (3H) of fentanyl |
123 |
1986 |
|
RIA screening (123I) of fentanyl |
126 |
1986 |
|
Detection & pain measurement |
127 |
1989 |
|
Pharmacology of methylated analogs of
fentanyl |
133 |
1989 |
|
Review of fentanyl |
134 |
1988 |
|
PCFIA detection of fentanyls |
136 |
1987 |
|
RIA, PCFIA & ELISA detection |
137 |
1987 |
|
ELISA detection of fentanyls |
140 |
1988 |
|
RIA & ELISA detection of fentanyls,
alfentanil |
148 |
1988 |
|
Detection of detomidine by RIA |
153 |
1989 |
|
ELISA & RIA detection of fentanyls,
alfentanil |
155 |
1989 |
|
Tranquilizers, local anesthetics and... |
168 |
1989 |
|
Detomidine clearance by ELISA |
180 |
1992 |
|
Immobilization of goats using
detomidine |
210 |
1997 |
|
Amitraz, detomidine and locomotor
activity |
224 |
1997 |
|
Antinociception & sedative effect
of amitraz |
231 |
1998 |
|
Lack of anesthetic efficacy of fentanyl
in abaxial sesamoid block model |
245 |
1999 |
|
Amitraz, detomidine, acepromazine and
activity |
250 |
1997 |
|
Detection of remifentanil |
270 |
2000 |
|
Serum concentrations, effects of oral
detomidine |
271 |
2002 |
|
Detection
of metabolite of remifentanil |
280 |
2000 |
|
ELISA
detection of remifentanil |
283 |
2000 |
|
Biotransformation, pharmacokinetics of
guanabenz |
289 |
2003 |
|
Comparative clinical effects,
pharmacodynamics |
290 |
|
|
Pharmacodynamics of guanabenz and
related ... |
299 |
|
|
ELISA assay for guanabenz |
314 |
|
|
Detection and confirmation method for
amitraz |
322 |
|
|
ELISA assay for guanabenz |
333 |
|
| ANILERIDINE |
|
|
|
|
Behavioral response (foot-step counts) |
39 |
1979 |
|
Locomotor response |
59 |
1979 |
| ANTIBIOTICS |
|
|
|
|
Chemotherapy in the horse |
35 |
1978 |
|
Review: streptomycin, gentamicin, etc |
52 |
1979 |
|
Overview in equine medicine |
60 |
1979 |
| AORC |
|
|
|
|
Uniform drug classification guidelines |
256 |
1998 |
| APOMORPHINE |
|
|
|
|
GC detection |
7 |
1976 |
|
TLC method |
36 |
1978 |
|
Locomotor response |
38 |
1979 |
|
Locomotor response |
59 |
1979 |
|
Enzyme hydrolysis & TLC detection |
70 |
1982 |
|
Locomotor activity |
250 |
1997 |
|
ELISA assay |
315 |
|
| AZAPERONE
(STRESNIL®) |
|
|
|
|
Metabolite identification |
178 |
1996 |
|
ELISA detection |
181 |
1992 |
| BEHAVIOR
CHAMBER |
|
|
|
|
Locomotor quantitation of medications |
217 |
1996 |
|
Development and characterization of;
also effects of amitraz, detomidine |
224 |
1997 |
|
Development and locomotor activity;
amitraz, detomidine, acepromazine |
250 |
1997 |
| BEHAVIOR
RESPONSE |
|
|
|
|
Procaine: Observed excitation |
5 |
1977 |
|
Procaine: Observed excitation |
10 |
1976 |
|
Methylphenidate: Variable interval
training |
20 |
1981 |
|
Pentazocine & fentanyl: Locomotor |
31 |
1979 |
|
TLC method for pentazocine |
36 |
1978 |
|
Narcotic
analgesics: Locomotor, eating |
39 |
1979 |
|
Reserpine: Locomotor |
42 |
1979 |
|
Reserpine: Locomotor |
43 |
1978 |
|
Reserpine & Cocaine: Variable
interval training |
58 |
1979 |
|
Narcotic analgesics: Locomotor |
59 |
1979 |
|
Review of behavioral models |
73 |
1982 |
|
Acepromazine:
Variable interval training |
74 |
1981 |
|
Acepromazine: Variable interval
training |
78 |
1982 |
|
Caffeine: Locomotor, enhanced fentanyl
response |
83 |
1983 |
|
Clenbuterol: Locomotor |
94 |
1983 |
|
Fentanyl: Skin twitch/ hoof withdrawal
latency |
106 |
1985 |
|
Ethylketazocine: Skin twitch/ hoof
withdrawal |
107 |
1986 |
|
U50,488H: Skin twitch/ hoof withdrawal,
locomotor |
125 |
1988 |
|
Hordenine: Variable interval training,
flehman |
129 |
1990 |
|
DADA: Observed responses |
135 |
1988 |
|
Locomotor quantitation of medications |
217 |
1996 |
|
Cocaine: Locomotor |
222 |
|
|
Quantitation of locomotor effect |
224 |
1997 |
| BENZOCAINE
(ETHYL AMINOBENZOATE) |
|
|
|
|
Highest no-effect dose determination |
189 |
1996 |
|
Local anesthetic efficacy |
190 |
1994 |
|
Highest
no-effect dose |
247 |
1995 |
| BENZOYLECGONINE |
|
|
|
|
ELISA detection |
176 |
1991 |
|
ELISA detection |
194 |
1996 |
|
Detection & significance |
214 |
2000 |
| BUMETANIDE
(BUMEX®) |
|
|
|
|
Use in horses |
14 |
1977 |
|
ELISA detection |
158 |
1994 |
| BUPIVACAINE |
|
|
|
|
Highest no-effect dose |
189 |
1996 |
|
Local anesthetic efficacy |
190 |
1994 |
|
Pharmacological effects &
analytical detection |
234 |
1999 |
|
Detection of 3-hydroxybupivacaine |
239 |
1998 |
|
Highest
no-effect dose |
247 |
1995 |
| BUPRENORPHINE
(BUPRENEX®) |
|
|
|
|
ELISA detection (in review) |
156 |
1989 |
| BUTORPHANOL
(STADOL®) |
|
|
|
|
Enzyme hydrolysis & TLC detection |
70 |
1982 |
|
Locomotor response |
73 |
1982 |
| CAFFEINE |
|
|
|
|
Pharmacology, pharmacokinetics &
behavior |
83 |
1983 |
|
Interpretation of positive results |
203 |
1994 |
|
Methylxanthines in the horse |
211 |
1998 |
|
ELISA development |
216 |
1996 |
|
Locomotor activity effects |
235 |
2001 |
|
Quantitation by ELISA vs GC |
267 |
2001 |
| CARFENTANIL
(WILDNIL®) |
|
|
|
|
PCFIA detection |
136 |
1987 |
|
RIA, PCFIA & ELISA detection |
137 |
1987 |
|
ELISA detection |
140 |
1988 |
|
RIA & ELISA detection |
148 |
1988 |
|
ELISA & RIA detection |
155 |
1989 |
|
Immobilization of goats |
210 |
1997 |
| CASSAINE |
|
|
|
|
Interaction with Na+K+-ATPase |
19 |
1977 |
| CELECOXIB |
|
|
|
|
Qualitative identification |
269 |
|
|
Identification and disposition |
277 |
2000 |
| CHLORAMPHENICOL |
|
|
|
|
Interaction with phenylbutazone
metabolism |
6 |
1977 |
| CHLORPROMAZINE
(THORAZINE®) |
|
|
|
|
Atypical conditions/ quantitative
recovery |
61 |
1981 |
|
Cross-rectivity with acepromazine ELISA |
144 |
1988 |
|
Cross-rectivity with acepromazine ELISA |
150 |
1988 |
| CLEARANCE
TIMES |
|
|
|
|
Pentazocine |
27 |
1979 |
|
Pentazocine, fentanyl |
31 |
1979 |
|
Urinary drug concentrations |
33 |
1978 |
|
Reappraisal |
71 |
1982 |
|
Clenbuterol |
94 |
1983 |
|
Drugs in horses |
165 |
1989 |
|
Pyrantel tartrate |
175 |
1991 |
|
Detomidine |
180 |
1992 |
|
HBPA Proposed National Policy on Drug
Testing and Therapeutic Medication |
330 |
2003 |
|
World rules on clearance times |
335 |
|
| CLENBUTEROL |
|
|
|
|
Clearance times & behavioral
effects |
94 |
1983 |
|
Behavior chamber |
265 |
|
|
ELISA & GC/MS detection (IT dose) |
268 |
2000 |
|
Urinary concentrations: ELISA &
GC/MS |
274 |
2001 |
|
LC/MS/MS quantitation in serum |
275 |
2001 |
|
Method for detection in serum |
281 |
2000 |
|
Synthesis of deuterated standard &
metabolites |
284 |
2000 |
| COCAINE |
|
|
|
|
Variable interval conditioning response |
58 |
1979 |
|
Locomotor & head bowing responses |
73 |
1982 |
|
PCFIA detection |
152 |
1989 |
|
ELISA detection |
176 |
1991 |
|
Highest no-effect dose determination |
189 |
1996 |
|
Local anesthetic efficacy |
190 |
1994 |
|
ELISA and GC/MS quantification |
194 |
1996 |
|
Interpretation of positive results |
203 |
1994 |
|
Behavior, ELISA & GC/MS |
222 |
|
|
Benzoylecgonine detection |
214 |
2000 |
|
Highest
no-effect dose |
247 |
1995 |
|
LC/MS/MS method |
282 |
2000 |
|
Highest no-effect dose, elimination
pattern |
310 |
2002 |
|
Hepatotoxicity |
329 |
1992 |
| COLORIMETRY |
|
|
|
|
Procaine method |
2 |
1976 |
|
Procaine method |
3 |
1976 |
|
Procaine method |
4 |
1977 |
|
Procaine method |
5 |
1977 |
|
Procaine method |
15 |
1977 |
| COTININE |
|
|
|
|
ELISA detection |
177 |
1993 |
|
Cross-rectivity with hydroxycotinine
ELISA |
183 |
1996 |
| CORTICOSTEROIDS |
|
|
|
|
Review |
45 |
1979 |
|
Pharmacology in the horse |
63 |
1980 |
|
Anti-inflammatory agents |
163 |
1989 |
|
Clinical use & characteristics |
185 |
1993 |
| CYANIDE |
|
|
|
|
Analytical detection and
"normal" population data |
298 |
|
|
Spectrophotometric detection method |
306 |
2003 |
|
Toxicokinetics in the horse |
307 |
|
|
Pharmacokinetics of cyanide and
mandelonitrile; relevance to MRLS |
309 |
|
|
Cherry trees, plant cyanogens,
caterpillars and MRLS |
316 |
2003 |
| DETECTION
TIMES |
|
|
|
|
Reappraisal |
71 |
1982 |
|
Uncertainty |
119 |
1986 |
|
Drugs in racing horses |
165 |
1989 |
|
Pyrantel tartrate |
179 |
1992 |
|
Albuterol |
295 |
2002 |
|
Albuterol |
297 |
|
|
Factors affecting detection times for
NSAIDS (presentation) |
326 |
|
|
HBPA Proposed National Policy on Drug
Testing and Therapeutic Medication |
330 |
2003 |
|
World rules on detection times |
335 |
|
| DETOMIDINE
(DOMOSEDAN®) |
|
|
|
|
Variable interval conditioning response |
132 |
1988 |
|
RIA detection |
153 |
1989 |
|
ELISA detection |
180 |
1992 |
|
Immobilization of goats |
210 |
1997 |
|
Locomotor activity |
250 |
1997 |
|
Delivery mediums and serum
concentrations |
271 |
2002 |
| DEUTERATED
COMPOUNDS |
|
|
|
|
Synthesis of clenbuterol analog |
284 |
2000 |
|
Synthesis and characterization of
deuterated furosemide |
301 |
|
| DICLAZURIL |
|
|
|
|
Detection and pharmacokinetics |
240 |
1998 |
|
Identification, detection &
pharmacokinetics |
242 |
1999 |
|
... and EPM |
248 |
1997 |
|
Preliminary pharmacokinetics |
249 |
1997 |
|
Clinical report |
254 |
2000 |
|
EPM therapy |
286 |
2001 |
|
Sodium salt formulation |
294 |
|
| DIETARY
SUBSTANCES |
|
|
|
|
Significance of dietary anthelmintic
pyrantel tartrate |
175 |
1991 |
|
Interim report on 1994 workshop |
194 |
1996 |
|
1994 Workshop Proceedings |
200 |
1995 |
|
Fifties rules, nineties testing |
202 |
1995 |
|
Overview of regulatory concern |
208 |
1995 |
|
Dietary, environmental and endogenous
substances |
212 |
1998 |
|
Workshop outcomes |
223 |
1996 |
|
Poisoning in horses |
226 |
1997 |
|
HBPA Proposed National Policy on Drug
Testing and Therapeutic Medication |
330 |
2003 |
| DIISOPROPYLAMINE
DICHLOROACETATE (DADA) |
|
|
|
|
Detection (GC), pharmacokinetics &
behavior |
135 |
1988 |
| DRUG
TESTING (GENERAL) |
|
|
|
|
Testing for drugs in horses |
44 |
1978 |
|
Drugs and performance testing in racing
horses |
54 |
1979 |
|
Testing for drugs in horses |
111 |
1986 |
| EFFICACY
AND COST OF TESTING (GENERAL DRUG TESTING) |
|
|
|
|
Illegal medications |
97 |
1985 |
|
Illegal medications |
115 |
1985 |
|
Drug testing |
121 |
1986 |
|
Non-isotopic immunoassays (review) |
156 |
1989 |
|
Testing for drugs and medications |
201 |
1995 |
|
Equine drug testing |
206 |
1998 |
|
Consequences of highly sensitive drug
testing |
233 |
1997 |
|
The need for limitations on the
sensitivity of testing for certain agents |
243 |
1998 |
|
Testing for therapeutic medications,
analytical/pharmacological relationships |
244 |
1999 |
|
Past and future of drug testing,
medication regulation (presentation) |
325 |
|
|
Pre-purchase and drug testing
(presentation) |
327 |
|
|
HBPA Proposed National Policy on Drug
Testing and Therapeutic Medication |
330 |
2003 |
|
"Test of Time" re: ELISA
testing (1990 Blood-Horse article) |
334 |
1990 |
| ELECTRO-ACUPUNCTURE |
|
|
|
|
Influence on pain threshold |
273 |
1999 |
| ELISA |
|
|
|
|
Carfentanil |
137 |
1987 |
|
Morphine |
138 |
1988 |
|
Fentanyl & congeners (methylfentanyls) |
140 |
1988 |
|
Mazindol |
141 |
1988 |
|
Furosemide |
143 |
1988 |
|
Acepromazine |
144 |
1988 |
|
Furosemide |
146 |
1988 |
|
Mazindol |
147 |
1988 |
|
Fentanyl & fentanyl derivatives |
148 |
1988 |
|
Morphine |
149 |
1988 |
|
Acepromazine |
150 |
1988 |
|
Phenylbutazone |
154 |
1989 |
|
Fentanyl, alfentanil, sufentanil,
carfentanil |
155 |
1989 |
|
Review |
156 |
1989 |
|
Ethacrynic acid & bumetanide |
158 |
1994 |
|
Pre-race testing |
160 |
1988 |
|
Post-race testing |
161 |
1988 |
|
Backgrounds, sensitivity, pooling, no.
of tests |
162 |
1990 |
|
Equine medication control |
171 |
1989 |
|
Morphine & etorphine |
173 |
1991 |
|
Benzoylecgonine & cocaine |
176 |
1991 |
|
Cotinine |
177 |
1993 |
|
Detomidine |
180 |
1992 |
|
Azaperone |
181 |
1992 |
|
Procaine |
182 |
1992 |
|
trans-3'-Hydroxycotinine |
183 |
1996 |
|
Cocaine quanitification |
194 |
1996 |
|
Remifentanil (Fentanyl Group) |
283 |
2000 |
|
Caffeine |
216 |
1996 |
|
Flunixin |
219 |
1996 |
|
Methocarbamol |
220 |
1996 |
|
Cocaine quanitification |
222 |
|
|
Lidocaine identification |
261 |
2000 |
|
Caffeine: ELISA vs GC |
267 |
2001 |
|
Urinary concentrations of clenbuterol |
274 |
2001 |
|
Fentanyl group ELISA for detection of
remifentanil, other narcotic analgesics |
283 |
2000 |
|
Stanozolol |
288 |
2000 |
|
Guanabenz |
289 |
2003 |
|
Albuterol |
295 |
2002 |
|
Albuterol |
297 |
|
|
Amphetamine |
312 |
|
|
Ketamine |
313 |
|
|
Guanabenz |
314 |
|
|
Apomorphine |
315 |
|
|
Guanabenz |
333 |
|
|
Overview of testing |
334 |
1990 |
| ENDOGENOUS
SUBSTANCES |
|
|
|
|
Workshop Proceedings |
200 |
1995 |
|
Fifties rules, nineties testing |
202 |
1995 |
|
Overview of regulatory concern |
208 |
1995 |
|
Dietary, environmental and endogenous
substances |
212 |
1998 |
|
Workshop outcomes |
223 |
1996 |
|
HBPA Proposed National Policy on Drug
Testing and Therapeutic Medication |
330 |
2003 |
| ENDOTOXIC
SHOCK |
|
|
|
|
Effects of naloxone |
79 |
1984 |
|
-Phenylbutylnitrone
effect on endotoxin toxemia |
205 |
1997 |
| ENKEPHALINS |
|
|
|
|
Locomotor activity |
80 |
1982 |
| ENVIRONMENTAL
ASSURANCE |
|
|
|
|
Release from petroleum storage tanks |
207 |
1995 |
| ENVIRONMENTAL
SUBSTANCES |
|
|
|
|
Workshop Proceedings |
200 |
1995 |
